Posted by
LIVING Your Legend: by Dellann Elliott Mydland, Co-Founder, CEO, President & Board Chair

LIVING Your Legend: by Dellann Elliott Mydland, Co-Founder, CEO, President & Board Chair

I am proud to announce our new BLOG Post Series, titled “LIVING Your Legend” in honor of celebrating 20 years of living the mission. Today, while going through old patient and caregiver files dating all the way back to 2002, I honestly had a moment, actually more than a moment – have pretty much taken […]

Posted by
“Incisionless Surgery” Treatment Approach: Metabolic Targeting of GBM

“Incisionless Surgery” Treatment Approach: Metabolic Targeting of GBM

This month’s CURE MAG Cover Tip brought to you by the End Brain Cancer Initiative (EBCI), www.EndBrainCancer.org,  and through our patient advocacy and disease education partnership with CURE, focuses on turning Glioblastoma Multiforme (GBM) from a deadly disease into a chronic managed disease through turning GBM patients into cancer survivors through metabolic targeting of GBM […]

Posted by

Expanded Use of Innovative Brain Tumor Treatment Exemplified in GT Medical Technologies’ 2020 GammaTile® Therapy

To all our Supporters, Friends and Colleagues and especially to the Patients and Caregivers we serve and to the Healthcare Workers who tirelessly work on behalf of all of us! First of all, I want to take this opportunity to mark the passing of a momentous year and wish everyone a much better 2021. It […]

Posted by

KIYATEC – A potential game-changer in informing your brain tumor treatment decision

Hi guys!  I am extremely excited to share what I believe is groundbreaking news in the battle against brain cancer and other solid tumors. In this case, it’s a response-prediction test which improves outcomes by testing live cancer cells against a number of potential therapies to demonstrate which ones will be most effective in killing […]

Posted by
Brain Tumor Patients and the COVID-19 Crisis – The Musella Foundation w/ Eric T. Wong, M.D.

Brain Tumor Patients and the COVID-19 Crisis – The Musella Foundation w/ Eric T. Wong, M.D.

WEBINAR! COVID-19 & BRAIN CANCER! Important information on how COVID-19 affects Brain Cancer (and other cancer) patients. Join Al Musella of the Musella Foundation and Dr. Eric T. Wong, Brain Tumor Center & Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, Dana Farber/Harvard Cancer Center and Harvard Medical School.  

Posted by
Book Launches with Call for Stories: Author and Advocate Dellann Elliott Mydland Calls for Stories Where Tragedy was Transformed for Good to Help Others

Book Launches with Call for Stories: Author and Advocate Dellann Elliott Mydland Calls for Stories Where Tragedy was Transformed for Good to Help Others

Book Launches with Call for Stories: Author and Advocate Dellann Elliott Mydland Calls for Stories Where Tragedy was Transformed for Good to Help Others SEATTLE, Aug. 27, 2019 /PRNewswire/ — Dellann Elliott Mydland, co-founder of the EndBrainCancer Initiative (EBCI), announces a new book she is writing to tell her story, and invites members of the […]

Posted by

With Condolences to the McCain Family, The End Brain Cancer Initiative Calls for New Access and Treatment Options for Brain Cancer Patients & Changes to Standard of Care

With Condolences to the McCain Family, The End Brain Cancer Initiative Calls for New Access and Treatment Options for Brain Cancer Patients & Changes to Standard of Care The End Brain Cancer Initiative (EBCI) joins other organizations to honor Senator McCain’s life and fight against brain cancer. EBCI calls for National Concerted Action that Offers […]

Posted by

The EndBrainCancer Initiative Received CITI Certification Becoming the First Brain Tumor Patient Advocacy Organization Listed as a Nationally-Recognized Recruiting Site

The EndBrainCancer Initiative Receives CITI Certification Becoming the First Brain Tumor Patient Advocacy Organization Listed as a Nationally-Recognized Recruiting Site FOR IMMEDIATE RELEASE Media Contact: Dellann Elliott Mydland Prestigious certification strengthens Seattle-based EBCI’s role in the brain tumor advocacy space directly connecting patients to Centers of Excellence, cutting edge treatments & development of promising clinical […]